ActiTrexx GmbH
Mainz
About ActiTrexx GmbH
ActiTrexx GmbH is a biotech start-up. They offer cellular therapy to prevent inflammatory reactions in conditions like GVHD, solid organ transplantation, and autoimmune diseases. Their ATREGA is a treatment option for transplanted patients, providing a substantial survival rate.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2021)
- Website: actitrexx.de
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/actitrexx-gmbh-114082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.